Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Bioequivalence Study of Two Formulations of 500 mg Metformin Extended Release Tablet

This study has been completed.
Information provided by (Responsible Party):
Dexa Medica Group Identifier:
First received: August 29, 2012
Last updated: August 30, 2012
Last verified: August 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2010
  Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)